Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 5 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 613.06 | 1445 / 1445 | 100% | 26.26 | 183 / 183 |
liver | 100% | 427.95 | 226 / 226 | 100% | 23.76 | 406 / 406 |
ovary | 100% | 833.76 | 180 / 180 | 100% | 42.37 | 430 / 430 |
kidney | 100% | 585.90 | 89 / 89 | 100% | 25.77 | 900 / 901 |
uterus | 100% | 697.03 | 170 / 170 | 100% | 37.73 | 458 / 459 |
skin | 100% | 759.44 | 1808 / 1809 | 100% | 33.64 | 471 / 472 |
breast | 100% | 682.81 | 459 / 459 | 100% | 36.93 | 1115 / 1118 |
thymus | 100% | 606.63 | 653 / 653 | 100% | 40.38 | 603 / 605 |
stomach | 100% | 508.66 | 359 / 359 | 100% | 31.62 | 285 / 286 |
prostate | 100% | 722.58 | 245 / 245 | 100% | 43.57 | 500 / 502 |
brain | 99% | 408.63 | 2627 / 2642 | 100% | 32.34 | 705 / 705 |
intestine | 100% | 639.58 | 966 / 966 | 99% | 35.85 | 524 / 527 |
bladder | 100% | 704.24 | 21 / 21 | 99% | 43.64 | 501 / 504 |
pancreas | 99% | 324.43 | 325 / 328 | 100% | 36.24 | 178 / 178 |
lung | 99% | 492.04 | 572 / 578 | 100% | 34.04 | 1155 / 1155 |
adrenal gland | 100% | 812.62 | 258 / 258 | 98% | 23.02 | 226 / 230 |
adipose | 100% | 626.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 31.77 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 44.69 | 29 / 29 |
spleen | 100% | 941.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 79.92 | 1 / 1 |
blood vessel | 100% | 567.99 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 458.15 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 356.23 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 476.70 | 867 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008089 | Biological process | anterograde axonal transport |
GO_0048490 | Biological process | anterograde synaptic vesicle transport |
GO_0050885 | Biological process | neuromuscular process controlling balance |
GO_0032438 | Biological process | melanosome organization |
GO_0070527 | Biological process | platelet aggregation |
GO_0031175 | Biological process | neuron projection development |
GO_0031083 | Cellular component | BLOC-1 complex |
GO_0005829 | Cellular component | cytosol |
GO_1904115 | Cellular component | axon cytoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | BLOC1S4 |
Protein name | Biogenesis of lysosome-related organelles complex 1 subunit 4 (BLOC-1 subunit 4) (Protein cappuccino homolog) |
Synonyms | CNO |
Description | FUNCTION: Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Plays a role in intracellular vesicle trafficking. . |
Accessions | ENST00000320776.5 Q9NUP1 |